Corporate Profile
- Corporate Profile
- Japan Clinic Co., Ltd.
- Establishment
- December 6th, 1974
- Head Office
-
1 Nishimachi, Taishogun Kita-ku, Kyoto, Japan. zip.603-8331
Tel : +81-75-465-3567 Fax : +81-75-465-3565
mail : japanclinic@japanclinic.co.jp
- CEO
- Yutaka Negishi
History
- 1974
-
- Japan Clinic Co., Ltd. commences operations with the sale of “Kaki” Tablets.
- Establishment of the Sendai Regional Sales Office.
- 1976
-
- Establishment of the Hiroshima and Sapporo Regional Sales Offices.
- 1978
-
- Establishment of the Food and Nutrition Counseling Office, offering after-sales services to our consumers.
- Signing of a business partnership with Mitsubishi Shokuhin Co., Ltd. (a subsidiary of Mitsubishi Corporation), resulting in the distribution of “Kaki” Tablets to pharmacies across Japan.
- 1979
-
- Signing of a business partnership with Sumitomo Corporation, resulting in the distribution of “Sea Milk” Tablets to pharmacies across Japan.
- 1981
-
- Completion of the Japan Clinic Head Office Building in Kyoto City.
- Establishment of the Tokyo Regional Sales Office.
- 1983
-
- Commences sale of the “Kaki” Drink.
- Establishment of the Central Research Center.
- 1984
-
- Construction of the Miyazu Factory complete.
- Foundation of the Japan Trace Nutrients Research Society, setting in motion a long history of joint studies with Universities in Japan, France, and the USA.
- 1985
-
- Successful isolation of Z-Substance from Oyster Extract, leading to the development of “Balanceter–Z”, an improved formula fortified with Z-Substance.
- Establishment of the Fukuoka Regional Sales Office.
- 1986
-
- Signing of a business partnership with the Japanese Liquor Merchants Cooperative Association, resulting in the distribution of Oyster Extract products liquor stores across Japan.
- 1991
-
- Establishment of the Nagoya Regional Sales Office.
- 1993
-
- Establishment of the Kansai Regional Sales Office.
- Obtains a patent in relation to a substance with platelet aggregation inhibiting properties. (Patent Number: 1770901 Japan)
- 1994
-
- Obtains a patent in relation to a substance with platelet aggregation inhibiting properties. (Patent Number: 1813693 Japan)
- Japan Clinic’s 20th Anniversary Ceremony held at Kyoto International Conference Center.
- Establishment of the JCOE Research Society organized by pharmacies from across Japan.
- 1995
-
- Obtains a patent in relation to a substance with brain lithium concentration augmentative properties. (Patent Number: 1906437 Japan)
- Obtains a patent in relation to a substance applicable to the treatment of schizophrenia. (Patent Number: 1932241 Japan)
- 1996
-
- Obtains patents in relation to substances with platelet aggregation inhibiting properties. (Patent Number: 2007451, 2007452 Japan)
- 1997
-
- Obtains a patent for the isolation of a low-molecular weight fraction of Oyster Extract. (Patent Number: 2129831 Japan)
- 1999
-
- Obtains a patent in relation to a substance with anti-oxidant properties and its production method. (Patent Number: 5925382 USA)
- 2000
-
- Hosts the first Annual JCOE Regional Administrator’s Assembly at the Miyako Hotel in Kyoto City.
- 2001
-
- Commences sale of the “Balanceter-WZ” Tablets. An Oyster Extract Tablet fortified with the FC-Substance.
- 2002
-
- “Balanceter–WZ” awarded the Lifestyle Reformation Award at the 2002 14th Topics Award sponsored by Drug Magazine Co., Ltd. and Yachiyo-Kai.
- Registration of the “Kaki-Niku Man” mascot character as Japan Clinic’s Trademark.
- Commences sale of the renewal formula version “Kaki 750 Drink” fortified with FC-Substance.
- Successful isolation of FC-Substance from Oyster Extract, leading to the obtainment of patents pertaining to the substance and its production method. (Patent Number: 3267962 Japan)
- 2003
-
- Signing of a trade agreement with a Hong Kong based company.
- Obtains patents pertaining to the FC-Substance and its production method, the W-Extraction Method. (Patent Number: 3429726 Japan)
Equivalent Patents Obtained :
2005(6884456, 6962723 USA)
2006(783771 Australia)
- 2005
-
- Commences sale of the renewal package version “Kaki” Tablet.
- 2006
-
- Obtains a patent pertaining to the extraction method of pure taurine from Oyster Extract. (Patent Number: 3819000 Japan)
- Hosts the first National JCOE Convention at the Westin Miyako Hotel in Kyoto.
- “Kaki” awarded the Renewal Product Award at the 2006 18th Topics Award sponsored by Drug Magazine Co., Ltd. and Yachiyo-Kai.
- Obtains a patent pertaining to the extraction method of a copper rich fractionation from Oyster Extract. (Patent Number: 3853816 Japan)
- 2007
-
- Establishment of the Food and Nutrition Counseling Office’s web-shop.
- 2008
-
- Obtains a patent pertaining to the production of salt derived from Oysters. (Patent Number: 4087890 Japan)
- Obtains a patent pertaining to a substance with anti-oxidant properties and its production method. (Patent Number: 4121583 Japan)
- Expansion of the Japan Trace Nutrients Research Society, and the hosting of the 25th annual Japan Trace Nutrients Research Society Academic Forum.
- Commences sale of the “Half-Sitoal Drink” – Recognized by the Consumer Affairs Agency of Japan as a “Food for Specified Health Uses – aka Tokuho”.
- 2009
-
- Hosts the second National JCOE Convention at the Westin Miyako Hotel in Kyoto.
- Obtains a patent pertaining to Oyster Extract containing a water-soluble form of zinc. (Patent Number: 4328842 Japan)
- 2010
-
- Commences sale of the “Balanceter - 1550” Drink.
- 2011
-
- Obtains a patent pertaining to the production method of Oyster Extract. (Patent Number: 4703574 Japan)
- 2013
-
- Japan Trace Nutrient Research Society’s 30th Annual Symposium takes place in Kyoto City.
- 2014
-
- Hosts the third National JCOE Convention at the Westin Miyako Hotel in Kyoto.
- 2016
-
- Completion of the Miyazu Factory renovation project.
- Miyazu Factory granted GMP certification by the Japan Health and Nutrition Food Association.
- 2017
-
- Relocation of the Head Office to Taishogun District in North Ward of Kyoto City.
- “Balanceter–WZ” awarded the Healthy Lifestyle Essentials Award at the 2017 29th Topics Award sponsored by Drug Magazine Co., Ltd. and Yachiyo-Kai.